Yinan Shen

1.4k total citations · 1 hit paper
37 papers, 855 citations indexed

About

Yinan Shen is a scholar working on Oncology, Genetics and Surgery. According to data from OpenAlex, Yinan Shen has authored 37 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Genetics and 10 papers in Surgery. Recurrent topics in Yinan Shen's work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Yinan Shen is often cited by papers focused on Virus-based gene therapy research (11 papers), CAR-T cell therapy research (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Yinan Shen collaborates with scholars based in China, Canada and United States. Yinan Shen's co-authors include Tingbo Liang, Danni Lin, Tian Yang, Jun‐Hua Lu, Mengchao Wu, Xueli Bai, Chengxiang Guo, Xiaozhen Zhang, Jianyong Yuan and Myron Schwartz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Hepatology.

In The Last Decade

Yinan Shen

36 papers receiving 847 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncolytic virotherapy: basic principles, recent advances and future directions

2023 213 citations Danni Lin, Yinan Shen et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Yinan Shen

Since Specialization

Citations

This map shows the geographic impact of Yinan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinan Shen more than expected).

Fields of papers citing papers by Yinan Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinan Shen. The network helps show where Yinan Shen may publish in the future.

Co-authorship network of co-authors of Yinan Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yinan Shen. A scholar is included among the top collaborators of Yinan Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinan Shen. Yinan Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma 2025 ·Cell Reports Medicine ·Guo Chen, Zhilin Long, (unknown), Yinan Shen, (unknown), Jingjing Qian, (unknown), (unknown), (unknown), Yue Ma, Jian Zheng, Jiayao Yang, Shuai Zhao, (unknown), (unknown), (unknown), Yujia Cai, Chen Wang, Qi Xie	0
2	Clinical outcomes from a phase I clinical trial of a novel oncolytic virus VG161 in patients with hepatocellular carcinoma (HCC) refractory after 2 prior lines of therapy including checkpoint inhibitors (CPI). 2024 ·Journal of Clinical Oncology ·Yinan Shen, (unknown), (unknown), Qian Tan, Ronghua Zhao, (unknown), Fang Tian, (unknown), Lei Wang, (unknown), Jun Ding, William Jia, (unknown), Yanal Murad, (unknown), (unknown), (unknown), Howard L. Kaufman, Xueli Bai, Tingbo Liang	6
3	The initial report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/RA payloads, in patients with advanced solid tumors. 2023 ·Journal of Clinical Oncology ·Siqing Fu, Madappa N. Kundranda, (unknown), Yinan Shen, Qian Tan, Ronghua Zhao, (unknown), Manu Pratap Singh, (unknown), Yanal Murad, Tingbo Liang	2
4	766 A clinical trial to evaluate the safety, tolerability and preliminary efficacy of VG161 in combination with Nivolumab in patients with advanced pancreatic cancer 2023 ·SHILAP Revista de lepidopterología ·Yinan Shen, (unknown), Yiting Qiu, (unknown), Wei Song, Fang Tian, (unknown), (unknown), Qian Tan, Ronghua Zhao, Xueli Bai, Tingbo Liang	2
5	Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy 2023 ·Journal of Medical Virology ·Xinyue Deng, Yinan Shen, Ming Yi, Chaomei Zhang, Bin Zhao, Guansheng Zhong, (unknown), (unknown), (unknown), (unknown), Ronghua Zhao, (unknown), Chenfang Dong, Zhijun Dai	15
6	Oncolytic virotherapy: basic principles, recent advances and future directions breakdown → 2023 ·Signal Transduction and Targeted Therapy ·Danni Lin, Yinan Shen, Tingbo Liang	213
7	VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes 2022 ·Journal of Medical Virology ·Yinan Shen, Wei Song, Danni Lin, Xiaozhen Zhang, Meng Wang, (unknown), (unknown), (unknown), Zijun Wang, Jianpeng Sheng, Yanal Murad, (unknown), Yufeng Lou, (unknown), (unknown), Ronghua Zhao, (unknown), Xueli Bai, Tingbo Liang	19
8	A preoperative nomogram predicts prognosis of patients with hepatocellular carcinoma after liver transplantation: a multicenter retrospective study 2021 ·BMC Cancer ·(unknown), Yinan Shen, Wei Zhang, Chengxiang Guo, Tingbo Liang, Xueli Bai	5
9	Preoperative transarterial chemoembolization for barcelona clinic liver cancer stage A/B hepatocellular carcinoma beyond the milan criteria: a propensity score matching analysis 2021 ·HPB ·Chengxiang Guo, (unknown), Zhengtao Hong, Junhui Sun, Wenbo Xiao, Ke Sun, Xuejie Li, Yinan Shen, Tingbo Liang, Xueli Bai	7
10	Combined targeted therapy and immunotherapy for cancer treatment 2021 ·World Journal of Clinical Cases ·Chengxiang Guo, Xing Huang, Jian Xu, Xiaozhen Zhang, Yinan Shen, Tingbo Liang, Xueli Bai	13
11	Oncolytic virus combined with traditional treatment versus traditional treatment alone in patients with cancer: a meta-analysis 2020 ·International Journal of Clinical Oncology ·(unknown), Yinan Shen, Tianyu Tang, Zengwei Tang, Wei Song, (unknown), Xiaozhen Zhang, Meng Wang, Xueli Bai, Tingbo Liang	8
12	A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma 2020 ·HPB ·Wen Chen, Tao Ma, Jian Zhang, Xiaozhen Zhang, Wei Chen, Yinan Shen, Xueli Bai, Tingbo Liang	50
13	Predicting surgical site infections using a novel nomogram in patients with hepatocelluar carcinoma undergoing hepatectomy 2019 ·World Journal of Clinical Cases ·Tianyu Tang, Yi Zong, Yinan Shen, Chengxiang Guo, Xiaozhen Zhang, (unknown), (unknown), Tingbo Liang, Xueli Bai	10
14	Pyogenic Liver Abscess After Pancreaticoduodenectomy: A Single-Center Experience 2019 ·Journal of Surgical Research ·Wen Chen, Tao Ma, Xueli Bai, Xiaozhen Zhang, Yinan Shen, Mengyi Lao, Guogang Li, Tingbo Liang	6
15	Preoperative prediction of peripancreatic vein invasion by pancreatic head cancer 2018 ·Cancer Imaging ·Yinan Shen, Chengxiang Guo, Yao Pan, Yi-Wen Chen, Tianyu Tang, Yuwei Li, Jun‐Hua Lu, Gang Jin, Renyi Qin, (unknown), Tingbo Liang, Xueli Bai	10
16	A preoperative nomogram predicts prognosis of up front resectable patients with pancreatic head cancer and suspected venous invasion 2018 ·HPB ·Yinan Shen, Xueli Bai, Gang Jin, Qi Zhang, Jun‐Hua Lu, Renyi Qin, Ri‐Sheng Yu, Yao Pan, Ying Chen, Peiwei Sun, Chengxiang Guo, Xiang Li, Tao Ma, Guogang Li, Shunliang Gao, Jianying Lou, Risheng Que, Wan Yee Lau, Tingbo Liang	12
17	Review of radiological classifications of pancreatic cancer with peripancreatic vessel invasion: are new grading criteria required? 2017 ·Cancer Imaging ·Yinan Shen, (unknown), (unknown), Tingbo Liang	16
18	TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization 2015 ·Cellular Physiology and Biochemistry ·Yinan Shen, Yongpeng Wei, (unknown), Yingying Jing, (unknown), Jianyong Yuan, Rong Li, Qiudong Zhao, Lixin Wei, Tian Yang, Jun‐Hua Lu	92
19	Risk Factors of Surgical Site Infection after Hepatic Resection 2014 ·Infection Control and Hospital Epidemiology ·Tian Yang, (unknown), Han Zhang, Jun‐Hua Lu, Yinan Shen, (unknown), Wan Yee Lau, Eric C. H. Lai, Chong‐De Lu, Mengchao Wu, Jiewei Li, Feng Shen	15
20	Elevated SHOX2 Expression is Associated with Tumor Recurrence of Hepatocellular Carcinoma 2013 ·Annals of Surgical Oncology ·Tian Yang, Han Zhang, (unknown), Yinan Shen, (unknown), Guang-Shun Yang, Mengchao Wu, Jun‐Hua Lu, Feng Shen	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact